What is the Current Status of Research and Development?
Research on amino acid transport inhibitors is ongoing, with several compounds in preclinical and clinical stages of development. For instance, JPH203 is a LAT1 inhibitor that has shown promising results in preclinical studies and is undergoing clinical trials. Similarly, V-9302 is an ASCT2 inhibitor being evaluated for its efficacy in various cancer models. These studies aim to establish the safety, optimal dosing, and therapeutic potential of these inhibitors in treating cancer.
